Evidence map›Paper›PMID 39461893›Full record

ReviewMacromolecular bioscience2024

Applications of Diels-Alder Chemistry in Biomaterials and Drug Delivery.

Tyus J Yeingst, Angelica M Helton, Daniel J Hayes

Abstract readReview
In one paragraph

Review in Macromolecular bioscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. The Diels-Alder Reaction as a Key Step in Natural Product Synthesis.Progress in the chemistry of organic natural products · 2026
    Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tyus J YeingstDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.
Angelica M HeltonDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.
Daniel J HayesDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.

Funding

Spatiotemporal Modulation of Osteogenesis in a 3-D Stromal/Stem Cell ModelR01DE024790 · NIDCR · PENNSYLVANIA STATE UNIVERSITY, THE · PI HAYES, DANIEL J. · 2015 to 2019
$1.7M
Ultrasound responsive hydrogels for stimulated combinatorial drug deliveryR21DE032155 · NIDCR · PENNSYLVANIA STATE UNIVERSITY, THE · PI HAYES, DANIEL J. · 2023 to 2023
$361k
Foundation for the National Institutes of Health R21DE032155National Defense Science and Engineering GraduateNIDCR NIH HHS R01 DE024790NIDCR NIH HHS R21 DE032155Office of the Under Secretary of Defense W81XWH2110052
6 · The paper itself

Abstract

Recent studies, leveraging click chemistry reactions, have significantly advanced the fields of biomaterials and drug delivery. Of these click reactions, the Diels-Alder cycloaddition is exceptionally valuable for synthetic organic chemistry and biomaterial design, as it occurs under mild reaction conditions and can undergo a retrograde reaction, under physiologically relevant conditions, to yield the initial reactants. In this review, potential applications of the Diels-Alder reaction are explored within the nexus of biomaterials and drug delivery. This includes an emphasis on key platforms such as polymers, nanoparticles, and hydrogels which utilize Diels-Alder for drug delivery, functionalized surfaces, bioconjugation, and other diverse applications. Specifically, this review will focus on the use of Diels-Alder biomaterials in applications of tissue engineering and cancer therapies, while providing a discussion of the advantages, platforms, and applications of Diels-Alder click chemistry.

Indexed as

Biocompatible MaterialsClick ChemistryCycloaddition ReactionDrug Delivery SystemsAnimalsHumansHydrogelsNanoparticlesNeoplasmsPolymersTissue EngineeringBiocompatible MaterialsHydrogelsPolymersbiomaterialscancer therapyDiels–Alderdrug‐deliverytissue engineering

Identifiers

PMID39461893
PMCPMC11648594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.